BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18998050)

  • 1. Successful cord blood transplantation for mycosis fungoides.
    Fukushima T; Horio K; Matsuo E; Imanishi D; Yamasaki R; Tsushima H; Imaizumi Y; Ohshima K; Hata T; Yoshida S; Miyazaki Y; Tomonaga M
    Int J Hematol; 2008 Dec; 88(5):596-598. PubMed ID: 18998050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome.
    Shiratori S; Fujimoto K; Nishimura M; Hatanaka KC; Kosugi-Kanaya M; Okada K; Sugita J; Shigematsu A; Hashimoto D; Endo T; Kondo T; Abe R; Hashino S; Matsuno Y; Shimizu H; Teshima T
    Hematol Oncol; 2016 Mar; 34(1):9-16. PubMed ID: 25312300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced-intensity conditioning followed by cord blood transplantation in a patient with refractory folliculotropic mycosis fungoides.
    Nakaike T; Kato K; Oku S; Hayashi M; Kikushige Y; Kuroiwa M; Takenaka K; Iwasaki H; Miyamoto T; Teshima T; Ohshima K; Akashi K
    Int J Hematol; 2013 Oct; 98(4):491-5. PubMed ID: 23943312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect.
    Burt RK; Guitart J; Traynor A; Link C; Rosen S; Pandolfino T; Kuzel TM
    Bone Marrow Transplant; 2000 Jan; 25(1):111-3. PubMed ID: 10654025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantation.
    Masood N; Russell KJ; Olerud JE; Sabath DE; Sale GE; Doney KC; Flowers ME; Fefer A; Thompson JA
    J Am Acad Dermatol; 2002 Jul; 47(1):140-5. PubMed ID: 12077596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of mycosis fungoides treated by reduced-intensity cord blood transplantation.
    Tsuji H; Wada T; Murakami M; Kashiwagi T; Ito Y; Ishida-Yamamoto A; Jimbo J; Shindo M; Sato K; Kohgo Y; Iizuka H
    J Dermatol; 2010 Dec; 37(12):1040-5. PubMed ID: 21083707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Duarte RF; Canals C; Onida F; Gabriel IH; Arranz R; Arcese W; Ferrant A; Kobbe G; Narni F; Deliliers GL; Olavarría E; Schmitz N; Sureda A
    J Clin Oncol; 2010 Oct; 28(29):4492-9. PubMed ID: 20697072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis.
    Goyal A; O'Leary D; Foss F
    Bone Marrow Transplant; 2024 Jan; 59(1):41-51. PubMed ID: 37853164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement.
    Doerschner M; Pekar-Lukacs A; Messerli-Odermatt O; Dommann-Scherrer C; Rütti M; Müller AM; Nair G; Kamarachev J; Kerl K; Beer M; Messerli M; Frauenknecht K; Haralambieva E; Hoetzenecker W; French LE; Guenova E
    Br J Dermatol; 2019 Dec; 181(6):1296-1302. PubMed ID: 30565216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.
    Duvic M; Donato M; Dabaja B; Richmond H; Singh L; Wei W; Acholonu S; Khouri I; Champlin R; Hosing C
    J Clin Oncol; 2010 May; 28(14):2365-72. PubMed ID: 20351328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperacute graft-versus-host disease after bone marrow transplantation for mycosis fungoides.
    Takahashi T; Fujimoto N; Kito K; Tanaka T
    J Dermatol; 2015 Mar; 42(3):327-8. PubMed ID: 25571971
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transformed juvenile-onset mycosis fungoides: treatment by bone marrow transplantation with graft-versus-lymphoma effect].
    Carrié E; Buzyn A; Fraitag S; Hermine O; Bodemer C
    Ann Dermatol Venereol; 2007 May; 134(5 Pt 1):471-6. PubMed ID: 17507848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on skin directed therapies in mycosis fungoides.
    Lovgren ML; Scarisbrick JJ
    Chin Clin Oncol; 2019 Feb; 8(1):7. PubMed ID: 30525757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete remission of stage IV erythrodermic mycosis fungoides with large cell transformation through combination of pralatrexate and romidepsin followed by allogeneic hematopoietic stem cell transplantation.
    Frederiks AJ; Creeper KJ; Spagnolo DV; Cannell P; Radeski D
    Australas J Dermatol; 2021 Aug; 62(3):e400-e403. PubMed ID: 34028795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary Syndrome.
    Virmani P; Zain J; Rosen ST; Myskowski PL; Querfeld C
    Dermatol Clin; 2015 Oct; 33(4):807-18. PubMed ID: 26433851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic response to brentuximab vedotin in refractory nontransformed CD30
    Mahévas T; Ram-Wolff C; Battistella M; Pennamen MDV; Rivet J; Brice P; Bagot M
    Br J Dermatol; 2019 Jun; 180(6):1517-1520. PubMed ID: 30269331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern therapy of mycosis fungoides].
    Roenigk HH
    Hautarzt; 1983 Jun; 34(6):266-72. PubMed ID: 6874333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.
    Molina A; Zain J; Arber DA; Angelopolou M; O'Donnell M; Murata-Collins J; Forman SJ; Nademanee A
    J Clin Oncol; 2005 Sep; 23(25):6163-71. PubMed ID: 16135483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durable remission of Sézary syndrome after unrelated bone marrow transplantation by reduced-intensity conditioning.
    Kahata K; Hashino S; Takahata M; Fujisawa F; Kondo T; Kobayashi S; Fujita Y; Shimizu H; Imamura M; Asaka M
    Acta Haematol; 2008; 120(1):14-8. PubMed ID: 18716396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.